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CASE STUDY
Modulatory effect of protocatechuic 
acid on cadmium induced nephrotoxicity 
and hepatoxicity in rats in vivo
Stephen A. Adefegha, Olasunkanmi S. Omojokun* and Ganiyu Oboh
Abstract 
Introduction: This study sought to investigate the effect of protocatechuic acid (PCA); a phenolic compound readily 
available in most plant foods on cadmium-induced nephrotoxicity and hepatoxicity in rats.
Case description: Thirty six adult male rats weighing about 150–160 g were acclimatized for 2 weeks and subse-
quently divided into six groups: Group 1 rats received normal saline (control group), group 2 rats were administered 
5 mg Cd/kg body weight in form of solution orally (induced group), groups 3 and 4 received cadmium solution and 
different doses of PCA (10 and 20 mg/kg body weight) respectively, while groups 5 and 6 were the normal rats admin-
istered different doses of PCA (10 and 20 mg/kg) respectively in an experiment that lasted for twenty one days. The 
animals were sacrificed, the blood was collected and the serum was subsequently prepared. Furthermore, the liver 
was excised, homogenized and centrifuged to obtain the tissue homogenate used for the analyses. The serum was 
used for the determination of the total protein, urea, creatinine and uric acid levels while the liver homogenate was 
used for the estimation of alanine aminotransferase (ALT), aspartate transaminase (AST), and alkaline phosphatase 
(ALP).
Discussion and evaluation: The result revealed that total protein level was reduced in cadmium induced toxicity rat 
group which was elevated upon treatment with PCA. Conversely, the elevated levels of urea, uric acid and creatinine 
in cadmium induced toxicity kidney rats were significantly (p < 0.05) reduced in PCA treated groups. Similarly, marked 
elevation in the ALT, AST and ALP activity were observed in cadmium induced toxicity rat group when compared 
with the control group. However, significant (p < 0.05) decrease in ALT, AST and ALP activity were noticed in groups 
administered different doses of PCA.
Conclusions: The results from this study suggest that PCA may protect against cadmium-induced toxicity in the 
kidney and liver.
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Background
Cadmium (Cd) is a heavy metal obtained as a by-prod-
uct of zinc. It is one of the most toxic environmental 
and industrial pollutants, obtained through consump-
tion of foods and drinking water, inhaled from air or 
cigarette smoking or from ingestion of contaminated 
soil and dust. It is a long biological half-life, toxic and 
non-biodegradable metal that is non-beneficial to plants, 
animals and humans (Jarup et al. 2000). The most impor-
tant target organ for chronic low-level exposure to Cd is 
the kidney and is reflected in proteinuria, calciuria, ami-
noaciduria, glycosuria and tubular necrosis (Satarug et al. 
2010) which may eventually lead to end-stage renal fail-
ure, deregulated blood pressure, diabetic complications 
and osteoporosis (Satarug and Moore 2004). In addition, 
Cd has the propensity to settle in the proximal tubule of 
the nephron, leading to nephrotoxicity (Ahn et al. 1999).
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Cd shows different mechanisms of toxicity under dif-
ferent experimental conditions and in various species. 
When some toxicants enter into the human system they 
result in disturbance in the redox balance in cells in 
favour of oxidants, with the imbalance resulting in oxi-
dative stress which eventually results in oxidative damage 
to the cellular macromolecules and cellular structures 
(Waisberg et al. 2003). Although, the biochemical mecha-
nism behind Cd nephrotoxicity and hepatotoxicity is not 
perfectly understood, once taken up enterally, Cd reaches 
the liver where it binds to metallothioneins (MTs), glu-
tathione (GSH) and other proteins or peptides (Thevenod 
2009). Even though, mitochondria have been identified as 
the earliest target organelles of Cd-induced nephrotoxic-
ity, antioxidants are known to protect against oxidative 
stress and Cd-induced nephrotoxicity (Tang and Shaikh 
2001).
Protocatechuic acid (PCA) which is chemically known 
as 3, 4-hydroxybenzoic acid is a widely distributed nat-
urally occurring phenolic acid and also one of the main 
metabolites of complex polyphenols which are normally 
found at high concentrations in vegetables and fruit, and 
are readily absorbed by animals and humans (Vitaglione 
et al. 2007). Protocatechuic acid has multifaceted biologi-
cal effects by acting on different molecular targets as it 
is shown to possesses antioxidant, anti-inflammatory 
as well as anti-hyperglycemic activities (Lin et al. 2009). 
However, there are new insights in the comprehension 
of the cellular and molecular mechanisms responsible 
for the potential preventive/therapeutic activity of PCA 
against a number of human diseases, but there is a dearth 
of information on its nephro-protective and hepato-pro-
tective mechanism. Hence we propose in this study to 
investigate possible modulatory effect of Protocatechuic 
acid on liver marker enzymes and kidney parameters in 
cadmium-induced hepatotoxicity and nephrotoxicity in 
rats in vivo.
Materials and case descriptions
Materials
Kits used for bioassay (total protein, urea, uric acid, cre-
atinine, ALT, AST and ALP) were sourced from Randox 
Laboratories Ltd., Crumlin, County Antrim, UK. Except 
where otherwise stated, all chemicals used were sourced 
from Sigma Co. (St Louis MO, USA). The water used was 
glass distilled.
Experimental animal and treatment groups
Thirty six adult male Wistar rats weighing about 150–
160 g were purchased from Central Animal House Uni-
versity of Ibadan, Oyo state. In this work, six groups were 
taken; each group comprised six male healthy rats. The 
first group served as control group with a normal feed 
and normal saline which is used as the positive control 
group, the induced group (group II) received cadmium 
chloride only orally (5  mg of Cd/kg of body weight in 
form of solution) which is the negative control. The third 
group received cadmium and 10 mg/kg PCA, the fourth 
group received cadmium and 20  mg/kg PCA, the fifth 
and sixth groups received (10 and 20 mg/kg body weight) 
PCA respectively. The rats were selected and kept in 
controlled conditions of about 12  h dark and 12  h light 
(alternative dark light cycle 12:12). All the animals were 
fed with a standard laboratory feed and water ad  libi-
tum. Care and treatment of the animals were performed 
accordingly. All the procedure were carried out orally. 
At the end of the experimental period, the animals were 
anaesthetized and sacrificed after overnight fast.
Animal ethics
The male Wistar rats used received humane care accord-
ing to the criteria outlined in the Guide for the Care and 
the Use of Laboratory Animals prepared by EU Directive 
2010/63/EU for animal experiments. The ethic regula-
tions have been followed in accordance with national 
and institutional guidelines for the protection of ani-
mals’ welfare during experiments. The experiment was 
carried out at the Functional Food, Nutraceuticals and 
Phytomedicine Laboratory, Department of Biochem-
istry, Federal University of Technology, Akure, Ondo 
State, Nigeria.
Homogenate preparation and Serum sample analysis
The rats were decapitated via cervical dislocation and the 
liver was rapidly dissected, placed in phosphate buffer 
pH 7.4 on ice and weighed. This tissue was subsequently 
rinsed with the phosphate buffer pH 7.4 and later homog-
enized with the phosphate buffer pH 7.4 (1:5 w/v), with 
about 10-up and down strokes at approximately 1200 
rev/min in a Teflon-glass homogenizer. The homogenate 
was centrifuged for 10 min at 3000 g to yield a pellet that 
was discarded and the supernatant was used for ALT, 
AST and ALP assay.
Function of kidney was assessed by measuring the con-
centration of total protein, urea, uric acid and creatinine 
in serum.
Methods
Determination of serum total protein concentration
The total protein concentration was determined using 
the method described by Lowry et  al. 10  µl of distilled 
water was pipetted into the test tube labeled blank, 10 µl 
of standard was added to the test tube labeled standard, 
and 10  µl of the sample was added to the sample test 
tube. 500 µl of Reagent was added to the three test tubes. 
The solution was mixed and incubated for 30  min at 
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25 °C after which absorbance was read at 540 nm (Lowry 
et al. 1951).
Determination of serum uric acid concentration
The uric acid concentration was determined using spec-
trophotometric method described by Collin and Diehl 
with slight modification by Morin and Prox. Briefly, 
20 μL of distilled water was added to 20 μL of the sam-
ple which was mixed with 1 mL of Hepes reagent (50 mM 
phosphate buffer, 4 mM 3,5-chloro-2-hydroxybenze-
nesulfonic acid) and enzyme reagent (0.25 mM 4-ami-
nophenazone, peroxidise, and uricase). Thereafter, the 
mixture was incubated for 5 min at 37 °C and the absorb-
ance at 520 nm was taken against reagent blank within 
30 min (Collin and Diehl 1959; Morin and Prox 1973). 
The uric acid concentration was subsequently calculated 
against the standard.
Determination of serum urea concentration
The urea concentration was determined using spectro-
photometric method described by Searcy et  al. Briefly, 
10 μL of sample was added to 0.1 mL of sodium nitro-
prusside—urease reagent (116 mM EDTA, 6 mM sodium 
nitroprusside, 1 g/L urease) after which the mixture was 
incubated for 10 min at 37 °C. 2.5 mL of 120 mM diluted 
phenol and 2.5 mL of 27 mM sodium hypochlorite solu-
tion containing 0.14 N sodium hydroxide which was then 
added to the reaction mixture. Thereafter, the mixture 
was incubated for 15 min at 37  °C and the absorbance 
at 546 nm was taken against reagent blank within 8  h 
(Searcy et  al. 1967). The urea concentration was subse-
quently calculated against the standard.
Determination of serum creatinine concentration
The creatinine concentration was determined using spec-
trophotometric alkaline Jaffe picrate method as described 
by Spierto et  al. Briefly, 50 μL of distilled water was 
added to 2 mL of working reagent (35 mM picric acid and 
0.32 M sodium hydroxide) before 50 μL of sample was 
added. Thereafter, the mixture was allowed to stay for 
30 s before taking absorbance. The absorbance at 492 nm 
was taken twice, firstly after 30  s and secondly after 
2 min (Spierto et al. 1979). The creatinine concentration 
was subsequently calculated against the standard, using 
change in the sample absorbance.
Determination of aspartate transaminase (AST) activity
This was carried out according to the method of Reitman 
and Frankel as described by the manufacturer’s manual 
(Randox Laboratories Ltd). Briefly, 100  μl of test sam-
ple was mixed with 500 μl of buffer (containing 100 mM 
phosphate buffer pH 7.4, 100  mM l-aspartate, and 
2  mM α-oxoglutarate) and the mixture was incubated 
for 30 min at 37 °C. Thereafter, 500 μl of 2 mM 2,4 dini-
trophenylhydrazine was added to the reaction mixture 
and allowed to stand for 20  min at 25  °C. Then, 500 μl 
of 0.4 mM NaOH was added and thoroughly mixed; the 
absorbance was read after 5 min at 546 nm against a rea-
gent blank and the AST activity determined (Reitman 
and Frankel 1957).
Determination of alanine aminotransferase (ALT) activity
This was carried out according to the method of Reit-
man and Frankel as described by the manufacturer’s 
manual (Randox Laboratories Ltd). Briefly, 100  μl of 
test sample was mixed with 500 μl of buffer (containing 
100 mM phosphate buffer pH 7.4, 200 mM l-alanine and 
2  mM α-oxoglutarate) and the mixture was incubated 
for 30 min at 37 °C. Thereafter, 500 μl of 2 mM 2, 4 dini-
trophenylhydrazine was added to the reaction mixture 
and allowed to stand for 20  min at 25  °C. Then, 500 μl 
of 0.4 mM NaOH was added and thoroughly mixed; the 
absorbance was read after 5 min at 546 nm against a rea-
gent blank and the AST activity determined (Reitman 
and Frankel 1957).
Determination of alkaline phosphatase activity (ALP)
The serum ALP concentration was determined using 
spectrophotometric method according to the recommen-
dations of Deutsche Gesellschaft fur Klinische Chemie,. 
Briefly, 20 μl of the test sample was mixed with 1 ml of 
reacting mixture (containing 1 M Diethanolamine buffer 
pH 9.8, 0.5  mM MgCl2 and 10  mM p-nitrophenylphos-
phate). The absorbance was then read at 1  min interval 
for 3  min at 405  nm and the ALP activity was subse-
quently determined (DGKC 1972).
Data analysis
The results of replicate readings were pooled and 
expressed as mean ±  standard deviation. Unpaired Stu-
dent’s t test was used for analyzing the data between two 
groups, whereas one-way analysis of variance (ANOVA) 
followed by multiple comparison tests (Tukey’s test) was 
employed for the post hoc (Zar 1984). GraphPad prism 6 
software package for Windows was used for the analysis. 
The level of significance was accepted at P < 0.05 for the 
assessment of in vivo biochemical parameters.
Case presentation
The effect of protocatechuic acid (PCA) on the protein 
level in rat serum induced with cadmium (5  mg of Cd/
kg B.W) as shown in Fig.  1 revealed that there was sig-
nificant (p < 0.05) reduction in protein level of cadmium-
treated rat group when compared with the normal 
control group. However, co-treatment of cadmium with 
10 or 20 mg/kg PCA significantly (p < 0.05) elevated the 
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protein level. Also, administration of PCA (10 or 20 mg/
kg) resulted in the elevation of the protein level with no 
significant (p > 0.05) difference when compared with nor-
mal control.
Furthermore, Fig.  2 revealed that cadmium adminis-
tration significantly (p < 0.05) increased the urea level in 
cadmium-treated rats when compared with the normal 
control group. However, co-treatment of cadmium with 
10 or 20 mg/kg PCA (Group 3 and 4 respectively) showed 
obvious significant (p  >  0.05) decrease in urea level. In 
addition, treatment with 10 or 20 mg/kg PCA (Group 5 
and 6 respectively) significantly (p  <  0.05) reduced the 
urea level when compared with cadmium–treated group. 
Similarly, there was a significant decrease (p  <  0.05) in 
urea level in normal rat treated with PCA (10 and 20 mg/
kg) when compared with the cadmium-treated group 
(Fig. 2). Although, the decrease in urea level of the 20 mg/
kg PCA group has slight significant (p < 0.05) difference 
from the normal control group, this could ascertain the 
20 mg/kg as the fixed dose for further biochemical stud-
ies. Similarly, Fig.  3 revealed that cadmium administra-
tion significantly (p < 0.05) increased the uric acid level 
in cadmium-treated group when compared with the nor-
mal control group. However, co-treatment of cadmium 
with 10 or 20 mg/kg PCA showed significant (p > 0.05) 
decrease in uric acid level. In addition, there was a sig-
nificant difference (p < 0.05) in uric acid level in normal 
rat treated with PCA (10 and 20 mg/kg) when compared 
with the cadmium-treated group as well as with nor-
mal control group. Also, Cd administration significantly 
(p  <  0.05) increased the creatinine level in Cd-treated 
negative control group when compared with the normal 
control group. However, there was a significant decrease 
(p  <  0.05) in creatinine level of rats in the groups co-
treated with cadmium and PCA (10 and 20 mg/kg) when 
compared with the cadmium-induced toxicity group 
(Fig. 4). Furthermore, no significant (p > 0.05) change was 
observed between the PCA (10 and 20  mg/kg) treated 
and normal control groups.
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Fig. 1 Effect of protocatechuic acid on total protein concentration in 
the serum of rats exposed to cadmium. $Group 2 (Cadmium-induced 
toxicity) significantly (p < 0.05) different from group 1 (normal 
control). *Group 3 (Cadmium + 10 mg/kg B.W PCA) and 4 (Cad-
mium + 20 mg/kg B.W PCA) significantly (p < 0.05) different from 
group 2 (Cadmium-induced toxicity). #Group 5 (10 mg/kg B.W PCA) 
and 6 (20 mg/kg B.W PCA) not significantly (p > 0.05) different from 
group 1(normal control)
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Fig. 2 Effect of protocatechuic acid on urea level in the serum of rats 
exposed to cadmium. $Group 2 (Cadmium-induced toxicity) signifi-
cantly (p < 0.05) different from group 1 (normal control). **Group 3 
(Cadmium + 10 mg/kg B.W PCA) and 4 (Cadmium + 20 mg/kg B.W 
PCA) very significantly (p < 0.05) different from group 2 (Cadmium-
induced toxicity). #Group 5 (10 mg/kg B.W PCA) not significantly 
(p > 0.05) different from group 1 (normal control). ðGroup 6 (20 mg/
kg B.W PCA) significantly (p < 0.05) different from group 1 (normal 
control)
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Fig. 3 Effect of protocatechuic acid on uric acid level in the serum of 
rats exposed to cadmium. $Group 2 (Cadmium-induced toxicity) sig-
nificantly (p < 0.05) different from group 1 (normal control). **Group 
3 (Cadmium + 10 mg/kg B.W PCA) and 4 (Cadmium + 20 mg/kg B.W 
PCA) very significantly (p < 0.05) different from group 2 (Cadmium-
induced toxicity). ðGroup 5 (10 mg/kg B.W PCA) and 6 (20 mg/kg B.W 
PCA) significantly (p < 0.05) different from group 1 (normal control)
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Figures 5, 6 and 7 displayed the effect of PCA on ALT, 
AST and ALP respectively. The liver enzyme activity in 
cadmium-induced hepatotoxicity in Wistar rats revealed 
that there was significant (p < 0.05) increase in ALT, AST 
and ALP activity of Cd-treated rat group when compared 
with the normal control group. However, the groups 
co-treated with cadmium and 10 or 20 mg/kg PCA sig-
nificantly (p  <  0.05) reduced the liver enzymes activity. 
Conversely, there was no significant (p > 0.05) difference 
in the enzymes activity following administration of PCA 
(10 or 20 mg/kg) when compared with the normal con-
trol group.
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Fig. 4 Effect of protocatechuic acid on creatinine level in the serum 
of rats exposed to cadmium. $Group 2 (Cadmium-induced toxic-
ity) significantly (p < 0.05) different from group 1 (normal control). 
*Group 3 (Cadmium + 10 mg/kg B.W PCA) significantly (p < 0.05) 
different from group 2 (Cadmium-induced toxicity). **Group 4 
(Cadmium + 20 mg/kg B.W PCA) very significantly (p < 0.05) different 
from group 2 (Cadmium-induced toxicity). #Group 5 (10 mg/kg B.W 
PCA) and 6 (20 mg/kg B.W PCA) not significantly (p > 0.05) different 
from group 1(normal control)
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Fig. 5 Effect of protocatechuic acid on ALT activity in the liver of 
rats exposed to cadmium. $Group 2 (Cadmium-induced toxicity) sig-
nificantly (p < 0.05) different from group 1 (normal control). *Group 
3 (Cadmium + 10 mg/kg B.W PCA) and 4 (Cadmium + 20 mg/kg 
B.W PCA) significantly (p < 0.05) different from group 2 (Cadmium-
induced toxicity). #Group 5 (10 mg/kg B.W PCA) and 6 (20 mg/kg 
B.W PCA) not significantly (p > 0.05) different from group 1(normal 
control)
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Fig. 6 Effect of protocatechuic acid on AST activity in the liver 
of rats exposed to cadmium. $Group 2 (Cadmium-induced toxic-
ity) significantly (p < 0.05) different from group 1 (normal control). 
*Group 3 (Cadmium + 10 mg/kg B.W PCA) significantly (p < 0.05) 
different from group 2 (Cadmium-induced toxicity). **Group 4 
(Cadmium + 20 mg/kg B.W PCA) very significantly (p < 0.05) different 
from group 2 (Cadmium-induced toxicity). #Group 5 (10 mg/kg B.W 
PCA) and 6 (20 mg/kg B.W PCA) not significantly (p > 0.05) different 
from group 1(normal control)
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Fig. 7 Effect of protocatechuic acid on ALP activity in the liver 
of rats exposed to cadmium. $Group 2 (Cadmium-induced toxic-
ity) significantly (p < 0.05) different from group 1 (normal control). 
μGroup 3 (Cadmium + 10 mg/kg B.W PCA) not significantly (p > 0.05) 
different from group 2 (Cadmium-induced toxicity). *Group 4 (Cad-
mium + 20 mg/kg B.W PCA) significantly (p < 0.05) different from 
group 2 (Cadmium-induced toxicity). #Group 5 (10 mg/kg B.W PCA) 
and 6 (20 mg/kg B.W PCA) not significantly (p > 0.05) different from 
group 1(normal control)
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Discussion
Protocatechuic acid (PCA) has attracted the interest 
of researchers in the last few years because of the anti-
oxidant activity. However, the possible mechanisms of 
action of PCA in liver and kidney protection have not 
been fully investigated. In this study, the significantly 
(p < 0.05) reduced total protein level in the Cd-treated rat 
group when compared with the normal control rats may 
be attributed to the oxidation of protein thereby forming 
protein-adduct leading to the oxidative damage. How-
ever, the significant (p < 0.05) elevation in the total pro-
tein level of Cd-treated rat group co-treated with PCA 
and also the normal rat groups treated with PCA may be 
as a result of injury on renal and hepatic cells induced by 
Cd intoxication which subsequently disturbed protein 
biosynthesis (Chawla 2003). However, this effect was 
more profound and effective in the PCA only treated 
group indicating the potential of PCA to regenerate dam-
aged renal and hepatic tissue, and thus increased protein 
synthesis in the damaged tissues (Salama and El-Bahr 
2007).
The increased levels of serum urea, uric acid and cre-
atinine in the Cd-treated rat group may be attributed to 
oxidative imbalance in the kidney causing elevated urea, 
uric acid and creatinine in the blood. Findings from this 
study correlate with the report given by Gilrolami et  al. 
where urea level was elevated as a result of Cd induction 
(Girolami et al. 1989). The significantly (p < 0.05) elevated 
level of creatinine in Cd-treated rat group when com-
pared with the normal rat group may be attributed to the 
oxidative damage to the kidney thereby allowing more 
release of creatinine into the blood. This is in agreement 
with earlier reports by Renugadevi and Prabu where Cd 
administration leads to an elevated level of creatinine 
(Renugadevi and Prabu 2009). This was also linked to the 
defect in filtration. Also, Shatti reported that rise in cre-
atinine level is an indication of renal–tubular damage due 
to Cd-induced nephrotoxicity (Shatti 2011). The reduc-
tion of the elevated urea, uric acid and creatinine level by 
cadmium may suggest that PCA exerts nephro-protective 
effect when exposed to Cd.
ALT and AST are considered to be established indi-
cators of hepatocellular damage (Al-Habori et  al. 2002). 
As a result of antioxidants/oxidants imbalance ratio in 
the cells, the levels of hepatic enzymes (ALT, AST and 
ALP) activities may indicate liver tissue damage prob-
ably by altered cell membrane permeability leading to 
the leakage of the enzymes from the tissue to the serum 
(Gaskill et al. 2005). In this study, a severe hepatic dam-
age was observed by the significant elevation of the 
hepatic enzymes ALT, AST and ALP activity in the serum 
of the Cd-induced hepatotoxicity group when compared 
with the normal control group. Finding from this study is 
similar to previously reported work by Soufy et  al. who 
reported the hepatotoxic effect of Cd in rats exposed 
to the metal (Renugadevi and Prabu 2009). They fur-
ther affirmed that these changes may be due to direct 
toxic effects of the toxicant (Cd) on hepatocytes since 
the liver is the site of detoxification of all types of toxins 
and chemicals (Renugadevi and Prabu 2009; Soufy et al. 
2007). The liver being the organ mostly associated with 
the detoxification and biotransformation of most for-
eign compounds that enter the body gets its regulating 
mechanism impaired as a result of accumulated toxicants 
which could result to the tissue damage (Camargo and 
Martinez 2006). This is in agreement with a report by Liu 
et al. that PCA exerts a potent attenuating effect on fat-
induced liver damage (Liu et al. 2010). Similarly, various 
studies have reported the in  vitro antioxidant potential, 
antibacterial effect and cancer chemopreventive activity 
of PCA (Li et al. 2011; Chao and Yin 2009; Tanaka et al. 
2011) showing its general pharmacological relevance. 
In this study, accumulation of Cd in the liver could be 
deployed to be what accounted for the hepatocellular 
injury noticed. Interestingly, serum levels of the renal 
functional markers and hepatic enzymes activities meas-
ured in this study were ameliorated upon co-treatment of 
Cd and PCA while no adverse effect was noticed follow-
ing PCA administration in rats suggesting a safe use of 
this plant based phenolic compound and the dose used in 
this study on the kidney and the liver.
Conclusion
From this study, it can be concluded that Cd induction of 
lipid peroxidation and elevation of liver marker enzymes 
and kidney parameters in the serum may interfere with 
the cellular balance in the kidney and liver thereby caus-
ing oxidative damage. However, PCA modulated Cd-
induced nephrotoxicity and hepatotoxicity in rats.
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